Considering their role in glycemic homeostasis, the benefits on body weight reduction and the recently shown protective effects on cardiovascular health, the use of GLP-1R agonist drugs (GLP-1RAs) is revolutionizing therapeutic approaches and not only for patients suffering from type 2 diabetes mellitus (T2DM) [3]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.